These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25268734)

  • 21. FcgammaRIII is protective against Pseudomonas aeruginosa pneumonia.
    Rhein LM; Perkins M; Gerard NP; Gerard C
    Am J Respir Cell Mol Biol; 2008 Apr; 38(4):401-6. PubMed ID: 17975174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa.
    Schultz MJ; Knapp S; Florquin S; Pater J; Takeda K; Akira S; van der Poll T
    Infect Immun; 2003 Apr; 71(4):1630-4. PubMed ID: 12654774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
    Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
    Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute intratracheal Pseudomonas aeruginosa infection in cystic fibrosis mice is age-independent.
    Munder A; Wölbeling F; Kerber-Momot T; Wedekind D; Baumann U; Gulbins E; Tümmler B
    Respir Res; 2011 Nov; 12(1):148. PubMed ID: 22059807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection.
    Véliz Rodriguez T; Moalli F; Polentarutti N; Paroni M; Bonavita E; Anselmo A; Nebuloni M; Mantero S; Jaillon S; Bragonzi A; Mantovani A; Riva F; Garlanda C
    Infect Immun; 2012 Jan; 80(1):100-9. PubMed ID: 22025515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
    Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.
    Patel VS; Sitapara RA; Gore A; Phan B; Sharma L; Sampat V; Li JH; Yang H; Chavan SS; Wang H; Tracey KJ; Mantell LL
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):280-7. PubMed ID: 23087050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
    Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
    Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection.
    Peñaloza HF; Olonisakin TF; Bain WG; Qu Y; van der Geest R; Zupetic J; Hulver M; Xiong Z; Newstead MW; Zou C; Alder JK; Ybe JA; Standiford TJ; Lee JS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Cytokine Induction Upon
    Kolbe U; Yi B; Poth T; Saunders A; Boutin S; Dalpke AH
    Front Immunol; 2020; 11():598636. PubMed ID: 33250899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice.
    Schultz MJ; Rijneveld AW; Florquin S; Speelman P; VAN Deventer SJH; VAN DER Poll T
    J Med Microbiol; 2001 Sep; 50(9):822-827. PubMed ID: 11549184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas aeruginosa-induced pneumonia.
    Benabid R; Wartelle J; Malleret L; Guyot N; Gangloff S; Lebargy F; Belaaouaj A
    J Biol Chem; 2012 Oct; 287(42):34883-34894. PubMed ID: 22927440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An essential role for non-bone marrow-derived cells in control of Pseudomonas aeruginosa pneumonia.
    Hajjar AM; Harowicz H; Liggitt HD; Fink PJ; Wilson CB; Skerrett SJ
    Am J Respir Cell Mol Biol; 2005 Nov; 33(5):470-5. PubMed ID: 16100080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice.
    Moser C; Johansen HK; Song Z; Hougen HP; Rygaard J; Høiby N
    APMIS; 1997 Nov; 105(11):838-42. PubMed ID: 9393554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
    Jeyaseelan S; Young SK; Yamamoto M; Arndt PG; Akira S; Kolls JK; Worthen GS
    J Immunol; 2006 Jul; 177(1):538-47. PubMed ID: 16785551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo.
    Allen L; Dockrell DH; Pattery T; Lee DG; Cornelis P; Hellewell PG; Whyte MK
    J Immunol; 2005 Mar; 174(6):3643-9. PubMed ID: 15749902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping genetic determinants of host susceptibility to Pseudomonas aeruginosa lung infection in mice.
    De Simone M; Spagnuolo L; Lorè NI; Cigana C; De Fino I; Broman KW; Iraqi FA; Bragonzi A
    BMC Genomics; 2016 May; 17():351. PubMed ID: 27169516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
    Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
    Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.